Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold temperature
There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
Nov. 24, 2020 • ~9 min
covid-19 immune-system pandemic vaccines sars-cov-2 antibody university-of-oxford astrazeneca covid-19-vaccines pfizerbiontech-vaccine moderna-vaccine pfizer-vaccine
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Nov. 16, 2020 • ~9 min
covid-19 pandemic sars-cov-2 remdesivir viruses antibody steroids monoclonal-antibodies convalescent-plasma dexamethasone
For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients’ antibody development and response, suggests a new study.
Nov. 13, 2020 • ~3 min
covid-19 health-medicine ragon-institute antibody-evolution igg-antibodies
Some have suggested the US allow healthy people to return to normal life, catch the coronavirus and get the population to herd immunity. The science says this plan is doomed to fail from the start.
Oct. 28, 2020 • ~10 min
covid-19 coronavirus donald-trump vaccines antibodies sars-cov-2 immunity herd-immunity viruses sweden antibody-testing death-rate case-fatality-rate
A new discovery offers hope for ways to treat a debilitating disease that has become a leading cause of death in the US..
Oct. 28, 2020 • ~8 min
health medicine inflammation smoking tobacco lungs antibodies lung-disease breathing cigarettes copd
COVID-19 causes some patients' immune systems to attack their own bodies, which may contribute to severe illness
Are antibodies that attack a patient's own organs contributing to severe forms of COVID-19? A new study suggests specific antibody tests that may reveal the answer.
Oct. 23, 2020 • ~8 min
covid-19 immune-system pandemic antibodies sars-cov-2 viruses autoimmune-diseases autoimmune-illness
SARS-CoV-2 antibodies persist in the body for months after infection. "This research… has armed us with the knowledge that lasting immunity is a reality."
Oct. 15, 2020 • ~7 min
covid-19 antibodies viruses featured health-and-medicine immune-systems
A new study shows that people who survive serious COVID-19 infections have long-lasting immune responses against the virus.
Oct. 8, 2020 • ~4 min
covid-19 health-medicine massachusetts-general-hospital antibodies long-lasting-immune-responses
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
Oct. 8, 2020 • ~8 min
covid-19 immune-system pandemic sars-cov-2 viruses infection cytokine-storm antibody autoimmune-diseases b-cell
One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19
Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
Oct. 1, 2020 • ~9 min
health medicine immune-system pandemic immunology sars-cov-2 covid-19-pandemic ace2 antibody innovation-and-invention covid-19-research
Page 1 of 7